​

Akari Therapeutics (AKTX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

AKTX Stock Forecast

Akari Therapeutics (AKTX) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $30.00, with a high of $30.00 and a low of $30.00. This represents a 254.61% increase from the last price of $8.46.

- $6 $12 $18 $24 $30 High: $30 Avg: $30 Low: $30 Last Closed Price: $8.46

AKTX Stock Rating

Akari Therapeutics stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (87.50%), 1 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 1 7 Strong Sell Sell Hold Buy Strong Buy

AKTX Price Target Upside V Benchmarks

TypeNameUpside
StockAkari Therapeutics254.61%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$30.00$30.00$30.00
Last Closing Price$8.46$8.46$8.46
Upside/Downside254.61%254.61%254.61%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26-11--2
Jun, 26-11--2
May, 26-21--3
Apr, 2613---4
Mar, 2613---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 20, 2026Maxim Group$30.00$11.01172.48%254.61%
Dec 05, 2022H.C. Wainwright$30.00$10.77178.55%254.61%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26
Dec 23Dec 24Dec 25Dec 26
Reported$-8.00$-66.40$-24.00-
Avg Forecast$-4.00$-3.40$-3.60-
High Forecast$-4.00$-3.40$-3.60-
Low Forecast$-4.00$-3.40$-3.60-
Surprise %100.00%1852.94%566.67%-

Revenue Forecast

$0 $8M $16M $24M $32M $40M Dec 23 Dec 24 Dec 25 Dec 26
Dec 23Dec 24Dec 25Dec 26
Reported----
Avg Forecast-$36.60M$3.54M$9.58M
High Forecast-$36.60M$3.54M$9.58M
Low Forecast-$36.60M$3.54M$9.58M
Surprise %----

Net Income Forecast

Dec 23 Dec 24 Dec 25 Dec 26
Dec 23Dec 24Dec 25Dec 26
Reported$-10.01M$-19.79M$-17.30M-
Avg Forecast$-19.58M$-16.64M$-17.62M-
High Forecast$-19.58M$-16.64M$-17.62M-
Low Forecast$-19.58M$-16.64M$-17.62M-
Surprise %-48.88%18.93%-1.83%-

AKTX Forecast FAQ

Is Akari Therapeutics stock a buy?

Akari Therapeutics stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Akari Therapeutics is a favorable investment for most analysts.

What is Akari Therapeutics's price target?

Akari Therapeutics's price target, set by 8 Wall Street analysts, averages $30 over the next 12 months. The price target range spans from $30 at the low end to $30 at the high end, suggesting a potential 254.61% change from the previous closing price of $8.46.

How does Akari Therapeutics stock forecast compare to its benchmarks?

Akari Therapeutics's stock forecast shows a 254.61% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Akari Therapeutics over the past three months?

  • July 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is Akari Therapeutics’s EPS forecast?

Akari Therapeutics's average annual EPS forecast for its fiscal year ending in December 2026 is $0, marking a -100.00% decrease from the reported $-24 in 2025..

What is Akari Therapeutics’s revenue forecast?

Akari Therapeutics's average annual revenue forecast for its fiscal year ending in December 2026 is $9.58M, reflecting a 0% decrease from the reported $0 in 2025.

What is Akari Therapeutics’s net income forecast?

Akari Therapeutics's net income forecast for the fiscal year ending in December 2026 stands at $0, representing a -100.00% decrease from the reported $-17.298M in 2025.